Ceapro Inc. announced the signing of an amendment to its long-term agreement with Symrise AG, for the distribution and commercialization of Ceapro's high value active ingredients to major key international players in the cosmetic market. The three-year agreement, signed on January 1, 2022, will now extend until December 31, 2026. Under the agreement, Symrise is guaranteed to purchase minimum annual volumes of Ceapro's highvalue active ingredients.

Financial terms of the agreement were not disclosed.